Commodore Capital LP
33 holdingsFiling period: 2026-06-30Current AUM: $1.50Bestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | RLAY | Relay Therapeutics Inc | 12.00M | $224.5M | $220.2M | 14.69% | -5,000,000 | 2026-06-30 |
| 2 | ELVN | Enliven Therapeutics Inc | 3.27M | $166.2M | $144.9M | 9.67% | -- | 2026-06-30 |
| 3 | — | Alkermes PLC | 3.00M | $157.2M | $157.2M | 10.49% | -1,200,000 | 2026-06-30 |
| 4 | COGT | Cogent Biosciences Inc | 3.05M | $118.0M | $94.6M | 6.31% | +162.0K | 2026-06-30 |
| 5 | AMLX | Amylyx Pharmaceuticals Inc | 5.65M | $101.5M | $163.1M | 10.88% | -- | 2026-06-30 |
| 6 | DFTX | Definium Therapeutics Inc | 2.00M | $94.1M | $72.7M | 4.85% | -- | 2026-06-30 |
| 7 | SYRE | Spyre Therapeutics Inc | 846.8K | $75.2M | $81.8M | 5.46% | -1,065,594 | 2026-06-30 |
| 8 | ANRO | Alto Neuroscience Inc | 2.72M | $71.9M | $61.5M | 4.11% | -- | 2026-06-30 |
| 9 | TNGX | Tango Therapeutics Inc | 2.25M | $70.3M | $51.1M | 3.41% | -- | 2026-06-30 |
| 10 | EYPT | Eyepoint Inc | 4.60M | $65.8M | $1.6M | 0.11% | +1.77M | 2026-06-30 |
| 11 | TYRA | Tyra Biosciences Inc | 1.88M | $59.9M | $39.5M | 2.64% | -600,000 | 2026-06-30 |
| 12 | DMRA | Damora Therapeutics Inc | 1.94M | $50.4M | $41.7M | 2.78% | -- | 2026-06-30 |
| 13 | CLDX | Celldex Therapeutics Inc New | 1.35M | $50.2M | $40.6M | 2.71% | -1,346,616 | 2026-06-30 |
| 14 | — | Pharvaris N V | 1.43M | $49.3M | $49.3M | 3.29% | -493,970 | 2026-06-30 |
| 15 | LBRX | LB Pharmaceuticals Inc | 1.50M | $48.7M | $59.5M | 3.97% | -- | 2026-06-30 |
| 16 | ASMB | Assembly Biosciences Inc | 1.42M | $38.9M | $28.5M | 1.90% | +415.0K | 2026-06-30 |
| 17 | EDIT | Editas Medicine Inc | 8.89M | $28.8M | $23.7M | 1.58% | -- | 2026-06-30 |
| 18 | KYMR | Kymera Therapeutics Inc | 250.0K | $28.7M | $31.7M | 2.11% | -500,000 | 2026-06-30 |
| 19 | CATX | Perspective Therapeutics Inc | 6.34M | $21.6M | $7.3M | 0.49% | -- | 2026-06-30 |
| 20 | IPSC | Century Therapeutics Inc | 8.70M | $21.3M | $12.8M | 0.85% | -- | 2026-06-30 |
| 21 | — | Zura Bio Ltd | 3.25M | $19.2M | $19.2M | 1.28% | -- | 2026-06-30 |
| 22 | AVTX | Avalo Therapeutics Inc | 1.02M | $18.8M | $7.3M | 0.49% | +535.3K | 2026-06-30 |
| 23 | — | Inflarx NV | 7.30M | $16.4M | $16.4M | 1.09% | -- | 2026-06-30 |
| 24 | ANTX | AN2 Therapeutics Inc | 2.93M | $14.2M | $13.3M | 0.89% | +600.0K | 2026-06-30 |
| 25 | NUVL | Nuvalent Inc | 100.0K | $12.3M | $12.3M | 0.82% | -733,600 | 2026-06-30 |
← Scroll →
Page 1 of 2